Global Cancer Respiratory Biopsy Market Research Report 2025

Cancer Respiratory Biopsy Market

Cancer respiratory biopsy is a non-invasive diagnostic technique that detects cancer by analyzing volatile organic compounds (VOCs) or other biomarkers in a patient's exhaled breath. These biomarkers may be generated by tumor metabolic activity and excreted through respiration. Compared to traditional tissue biopsies such as puncture or bronchoscopy biopsy, respiratory biopsy has advantages such as non invasiveness, convenience, and strong reproducibility, especially suitable for early screening and monitoring of respiratory diseases such as lung cancer. The detection methods usually involve techniques such as mass spectrometry, gas chromatography-mass spectrometry (GC-MS), sensors, etc.

In recent years, the global cancer respiratory biopsy market has maintained a growth trend. The increase in incidence rate of cancer (especially lung cancer), minimally invasive trend, technological progress and policy support are the main driving factors. Lung cancer is one of the cancers with the highest incidence in the world and China, which has promoted the demand for early non-invasive detection technology. Compared to traditional cancer biopsies, respiratory biopsies are safer and more widely accepted by patients. AI assisted analysis, improved sensor sensitivity, and multimodal image fusion (such as combining CT or MRI) have enhanced the accuracy of respiratory biopsy. In addition, early screening for cancer has been included in some countries' medical insurance, reducing the burden on patients and promoting the popularization of technology. The main participants include international companies such as Owlstone Medical, Breath Diagnostics, and Menssana Research, as well as domestic companies such as BREAX Biotech and ChromX Health. The main challenges facing the market include technological maturity, insufficient standardization, cost and promotion issues. The sensitivity and specificity of respiratory biopsy still need to be optimized and have not yet become the clinical gold standard. And there are significant differences in the biomarkers of different detection methods, lacking a unified standard. High research and development costs and equipment investment may limit the popularization of primary healthcare institutions. In the future, intelligence, portable devices, and multi cancer detection will be the main development trends in the industry. AI and machine learning will be used for real-time analysis of respiratory data to improve diagnostic efficiency. The development of miniaturized and wireless detection equipment will facilitate the use of community hospitals. In addition to lung cancer, companies will also expand their research into respiratory biomarkers for other cancers such as gastric cancer and colorectal cancer.

This report aims to provide a comprehensive presentation of the global market for Cancer Respiratory Biopsy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Respiratory Biopsy.

The Cancer Respiratory Biopsy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Respiratory Biopsy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cancer Respiratory Biopsy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cancer Respiratory Biopsy Market Report

Chapter Outline

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cancer Respiratory Biopsy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Mass Spectrometry Technology Based Respiratory Detection

1.2.3 Gas Chromatography-Mass Spectrometry Based Respiratory Detection

1.2.4 Sensor Based Respiratory Detection

1.3 Market by Application

1.3.1 Global Cancer Respiratory Biopsy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Lung Cancer Early Screening

1.3.3 Colorectal Cancer Detection

1.3.4 Liver Cancer Detection

1.3.5 Esophageal Cancer Detection

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2.1 Global Cancer Respiratory Biopsy Market Perspective (2020-2031)

2.2 Global Cancer Respiratory Biopsy Growth Trends by Region

2.2.1 Global Cancer Respiratory Biopsy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Cancer Respiratory Biopsy Historic Market Size by Region (2020-2025)

2.2.3 Cancer Respiratory Biopsy Forecasted Market Size by Region (2026-2031)

2.3 Cancer Respiratory Biopsy Market Dynamics

2.3.1 Cancer Respiratory Biopsy Industry Trends

2.3.2 Cancer Respiratory Biopsy Market Drivers

2.3.3 Cancer Respiratory Biopsy Market Challenges

2.3.4 Cancer Respiratory Biopsy Market Restraints

3.1 Global Top Cancer Respiratory Biopsy Players by Revenue

3.1.1 Global Top Cancer Respiratory Biopsy Players by Revenue (2020-2025)

3.1.2 Global Cancer Respiratory Biopsy Revenue Market Share by Players (2020-2025)

3.2 Global Top Cancer Respiratory Biopsy Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Cancer Respiratory Biopsy Revenue

3.4 Global Cancer Respiratory Biopsy Market Concentration Ratio

3.4.1 Global Cancer Respiratory Biopsy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cancer Respiratory Biopsy Revenue in 2024

3.5 Global Key Players of Cancer Respiratory Biopsy Head office and Area Served

3.6 Global Key Players of Cancer Respiratory Biopsy, Product and Application

3.7 Global Key Players of Cancer Respiratory Biopsy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Cancer Respiratory Biopsy Historic Market Size by Type (2020-2025)

4.2 Global Cancer Respiratory Biopsy Forecasted Market Size by Type (2026-2031)

5.1 Global Cancer Respiratory Biopsy Historic Market Size by Application (2020-2025)

5.2 Global Cancer Respiratory Biopsy Forecasted Market Size by Application (2026-2031)

6.1 North America Cancer Respiratory Biopsy Market Size (2020-2031)

6.2 North America Cancer Respiratory Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Cancer Respiratory Biopsy Market Size by Country (2020-2025)

6.4 North America Cancer Respiratory Biopsy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7.1 Europe Cancer Respiratory Biopsy Market Size (2020-2031)

7.2 Europe Cancer Respiratory Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Cancer Respiratory Biopsy Market Size by Country (2020-2025)

7.4 Europe Cancer Respiratory Biopsy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Cancer Respiratory Biopsy Market Size (2020-2031)

8.2 Asia-Pacific Cancer Respiratory Biopsy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Cancer Respiratory Biopsy Market Size by Region (2020-2025)

8.4 Asia-Pacific Cancer Respiratory Biopsy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Cancer Respiratory Biopsy Market Size (2020-2031)

9.2 Latin America Cancer Respiratory Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Cancer Respiratory Biopsy Market Size by Country (2020-2025)

9.4 Latin America Cancer Respiratory Biopsy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Cancer Respiratory Biopsy Market Size (2020-2031)

10.2 Middle East & Africa Cancer Respiratory Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Cancer Respiratory Biopsy Market Size by Country (2020-2025)

10.4 Middle East & Africa Cancer Respiratory Biopsy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Owlstone Medical

11.1.1 Owlstone Medical Company Details

11.1.2 Owlstone Medical Business Overview

11.1.3 Owlstone Medical Cancer Respiratory Biopsy Introduction

11.1.4 Owlstone Medical Revenue in Cancer Respiratory Biopsy Business (2020-2025)

11.1.5 Owlstone Medical Recent Development

11.2 Breath Diagnostics

11.2.1 Breath Diagnostics Company Details

11.2.2 Breath Diagnostics Business Overview

11.2.3 Breath Diagnostics Cancer Respiratory Biopsy Introduction

11.2.4 Breath Diagnostics Revenue in Cancer Respiratory Biopsy Business (2020-2025)

11.2.5 Breath Diagnostics Recent Development

11.3 Menssana Research

11.3.1 Menssana Research Company Details

11.3.2 Menssana Research Business Overview

11.3.3 Menssana Research Cancer Respiratory Biopsy Introduction

11.3.4 Menssana Research Revenue in Cancer Respiratory Biopsy Business (2020-2025)

11.3.5 Menssana Research Recent Development

11.4 Sensigent

11.4.1 Sensigent Company Details

11.4.2 Sensigent Business Overview

11.4.3 Sensigent Cancer Respiratory Biopsy Introduction

11.4.4 Sensigent Revenue in Cancer Respiratory Biopsy Business (2020-2025)

11.4.5 Sensigent Recent Development

11.5 Alpha Szenszor

11.5.1 Alpha Szenszor Company Details

11.5.2 Alpha Szenszor Business Overview

11.5.3 Alpha Szenszor Cancer Respiratory Biopsy Introduction

11.5.4 Alpha Szenszor Revenue in Cancer Respiratory Biopsy Business (2020-2025)

11.5.5 Alpha Szenszor Recent Development

11.6 NanoScent

11.6.1 NanoScent Company Details

11.6.2 NanoScent Business Overview

11.6.3 NanoScent Cancer Respiratory Biopsy Introduction

11.6.4 NanoScent Revenue in Cancer Respiratory Biopsy Business (2020-2025)

11.6.5 NanoScent Recent Development

11.7 Spira Innovation

11.7.1 Spira Innovation Company Details

11.7.2 Spira Innovation Business Overview

11.7.3 Spira Innovation Cancer Respiratory Biopsy Introduction

11.7.4 Spira Innovation Revenue in Cancer Respiratory Biopsy Business (2020-2025)

11.7.5 Spira Innovation Recent Development

11.8 Syft Technologies

11.8.1 Syft Technologies Company Details

11.8.2 Syft Technologies Business Overview

11.8.3 Syft Technologies Cancer Respiratory Biopsy Introduction

11.8.4 Syft Technologies Revenue in Cancer Respiratory Biopsy Business (2020-2025)

11.8.5 Syft Technologies Recent Development

11.9 Breathe Biomedical

11.9.1 Breathe Biomedical Company Details

11.9.2 Breathe Biomedical Business Overview

11.9.3 Breathe Biomedical Cancer Respiratory Biopsy Introduction

11.9.4 Breathe Biomedical Revenue in Cancer Respiratory Biopsy Business (2020-2025)

11.9.5 Breathe Biomedical Recent Development

11.10 Vocxi Health

11.10.1 Vocxi Health Company Details

11.10.2 Vocxi Health Business Overview

11.10.3 Vocxi Health Cancer Respiratory Biopsy Introduction

11.10.4 Vocxi Health Revenue in Cancer Respiratory Biopsy Business (2020-2025)

11.10.5 Vocxi Health Recent Development

11.11 BREAX Biotech

11.11.1 BREAX Biotech Company Details

11.11.2 BREAX Biotech Business Overview

11.11.3 BREAX Biotech Cancer Respiratory Biopsy Introduction

11.11.4 BREAX Biotech Revenue in Cancer Respiratory Biopsy Business (2020-2025)

11.11.5 BREAX Biotech Recent Development

11.12 ChromX Health

11.12.1 ChromX Health Company Details

11.12.2 ChromX Health Business Overview

11.12.3 ChromX Health Cancer Respiratory Biopsy Introduction

11.12.4 ChromX Health Revenue in Cancer Respiratory Biopsy Business (2020-2025)

11.12.5 ChromX Health Recent Development

11.13 Sunvou Medical

11.13.1 Sunvou Medical Company Details

11.13.2 Sunvou Medical Business Overview

11.13.3 Sunvou Medical Cancer Respiratory Biopsy Introduction

11.13.4 Sunvou Medical Revenue in Cancer Respiratory Biopsy Business (2020-2025)

11.13.5 Sunvou Medical Recent Development

11.14 MaiAoTech

11.14.1 MaiAoTech Company Details

11.14.2 MaiAoTech Business Overview

11.14.3 MaiAoTech Cancer Respiratory Biopsy Introduction

11.14.4 MaiAoTech Revenue in Cancer Respiratory Biopsy Business (2020-2025)

11.14.5 MaiAoTech Recent Development

11.15 Hanon Instruments

11.15.1 Hanon Instruments Company Details

11.15.2 Hanon Instruments Business Overview

11.15.3 Hanon Instruments Cancer Respiratory Biopsy Introduction

11.15.4 Hanon Instruments Revenue in Cancer Respiratory Biopsy Business (2020-2025)

11.15.5 Hanon Instruments Recent Development

11.16 WIM Spirare

11.16.1 WIM Spirare Company Details

11.16.2 WIM Spirare Business Overview

11.16.3 WIM Spirare Cancer Respiratory Biopsy Introduction

11.16.4 WIM Spirare Revenue in Cancer Respiratory Biopsy Business (2020-2025)

11.16.5 WIM Spirare Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables

 Table 1. Global Cancer Respiratory Biopsy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

 Table 2. Key Players of Mass Spectrometry Technology Based Respiratory Detection

 Table 3. Key Players of Gas Chromatography-Mass Spectrometry Based Respiratory Detection

 Table 4. Key Players of Sensor Based Respiratory Detection

 Table 5. Global Cancer Respiratory Biopsy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

 Table 6. Global Cancer Respiratory Biopsy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

 Table 7. Global Cancer Respiratory Biopsy Market Size by Region (2020-2025) & (US$ Million)

 Table 8. Global Cancer Respiratory Biopsy Market Share by Region (2020-2025)

 Table 9. Global Cancer Respiratory Biopsy Forecasted Market Size by Region (2026-2031) & (US$ Million)

 Table 10. Global Cancer Respiratory Biopsy Market Share by Region (2026-2031)

 Table 11. Cancer Respiratory Biopsy Market Trends

 Table 12. Cancer Respiratory Biopsy Market Drivers

 Table 13. Cancer Respiratory Biopsy Market Challenges

 Table 14. Cancer Respiratory Biopsy Market Restraints

 Table 15. Global Cancer Respiratory Biopsy Revenue by Players (2020-2025) & (US$ Million)

 Table 16. Global Cancer Respiratory Biopsy Market Share by Players (2020-2025)

 Table 17. Global Top Cancer Respiratory Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Respiratory Biopsy as of 2024)

 Table 18. Ranking of Global Top Cancer Respiratory Biopsy Companies by Revenue (US$ Million) in 2024

 Table 19. Global 5 Largest Players Market Share by Cancer Respiratory Biopsy Revenue (CR5 and HHI) & (2020-2025)

 Table 20. Global Key Players of Cancer Respiratory Biopsy, Headquarters and Area Served

 Table 21. Global Key Players of Cancer Respiratory Biopsy, Product and Application

 Table 22. Global Key Players of Cancer Respiratory Biopsy, Date of Enter into This Industry

 Table 23. Mergers & Acquisitions, Expansion Plans

 Table 24. Global Cancer Respiratory Biopsy Market Size by Type (2020-2025) & (US$ Million)

 Table 25. Global Cancer Respiratory Biopsy Revenue Market Share by Type (2020-2025)

 Table 26. Global Cancer Respiratory Biopsy Forecasted Market Size by Type (2026-2031) & (US$ Million)

 Table 27. Global Cancer Respiratory Biopsy Revenue Market Share by Type (2026-2031)

 Table 28. Global Cancer Respiratory Biopsy Market Size by Application (2020-2025) & (US$ Million)

 Table 29. Global Cancer Respiratory Biopsy Revenue Market Share by Application (2020-2025)

 Table 30. Global Cancer Respiratory Biopsy Forecasted Market Size by Application (2026-2031) & (US$ Million)

 Table 31. Global Cancer Respiratory Biopsy Revenue Market Share by Application (2026-2031)

 Table 32. North America Cancer Respiratory Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

 Table 33. North America Cancer Respiratory Biopsy Market Size by Country (2020-2025) & (US$ Million)

 Table 34. North America Cancer Respiratory Biopsy Market Size by Country (2026-2031) & (US$ Million)

 Table 35. Europe Cancer Respiratory Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

 Table 36. Europe Cancer Respiratory Biopsy Market Size by Country (2020-2025) & (US$ Million)

 Table 37. Europe Cancer Respiratory Biopsy Market Size by Country (2026-2031) & (US$ Million)

 Table 38. Asia-Pacific Cancer Respiratory Biopsy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

 Table 39. Asia-Pacific Cancer Respiratory Biopsy Market Size by Region (2020-2025) & (US$ Million)

 Table 40. Asia-Pacific Cancer Respiratory Biopsy Market Size by Region (2026-2031) & (US$ Million)

 Table 41. Latin America Cancer Respiratory Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

 Table 42. Latin America Cancer Respiratory Biopsy Market Size by Country (2020-2025) & (US$ Million)

 Table 43. Latin America Cancer Respiratory Biopsy Market Size by Country (2026-2031) & (US$ Million)

 Table 44. Middle East & Africa Cancer Respiratory Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

 Table 45. Middle East & Africa Cancer Respiratory Biopsy Market Size by Country (2020-2025) & (US$ Million)

 Table 46. Middle East & Africa Cancer Respiratory Biopsy Market Size by Country (2026-2031) & (US$ Million)

 Table 47. Owlstone Medical Company Details

 Table 48. Owlstone Medical Business Overview

 Table 49. Owlstone Medical Cancer Respiratory Biopsy Product

 Table 50. Owlstone Medical Revenue in Cancer Respiratory Biopsy Business (2020-2025) & (US$ Million)

 Table 51. Owlstone Medical Recent Development

 Table 52. Breath Diagnostics Company Details

 Table 53. Breath Diagnostics Business Overview

 Table 54. Breath Diagnostics Cancer Respiratory Biopsy Product

 Table 55. Breath Diagnostics Revenue in Cancer Respiratory Biopsy Business (2020-2025) & (US$ Million)

 Table 56. Breath Diagnostics Recent Development

 Table 57. Menssana Research Company Details

 Table 58. Menssana Research Business Overview

 Table 59. Menssana Research Cancer Respiratory Biopsy Product

 Table 60. Menssana Research Revenue in Cancer Respiratory Biopsy Business (2020-2025) & (US$ Million)

 Table 61. Menssana Research Recent Development

 Table 62. Sensigent Company Details

 Table 63. Sensigent Business Overview

 Table 64. Sensigent Cancer Respiratory Biopsy Product

 Table 65. Sensigent Revenue in Cancer Respiratory Biopsy Business (2020-2025) & (US$ Million)

 Table 66. Sensigent Recent Development

 Table 67. Alpha Szenszor Company Details

 Table 68. Alpha Szenszor Business Overview

 Table 69. Alpha Szenszor Cancer Respiratory Biopsy Product

 Table 70. Alpha Szenszor Revenue in Cancer Respiratory Biopsy Business (2020-2025) & (US$ Million)

 Table 71. Alpha Szenszor Recent Development

 Table 72. NanoScent Company Details

 Table 73. NanoScent Business Overview

 Table 74. NanoScent Cancer Respiratory Biopsy Product

 Table 75. NanoScent Revenue in Cancer Respiratory Biopsy Business (2020-2025) & (US$ Million)

 Table 76. NanoScent Recent Development

 Table 77. Spira Innovation Company Details

 Table 78. Spira Innovation Business Overview

 Table 79. Spira Innovation Cancer Respiratory Biopsy Product

 Table 80. Spira Innovation Revenue in Cancer Respiratory Biopsy Business (2020-2025) & (US$ Million)

 Table 81. Spira Innovation Recent Development

 Table 82. Syft Technologies Company Details

 Table 83. Syft Technologies Business Overview

 Table 84. Syft Technologies Cancer Respiratory Biopsy Product

 Table 85. Syft Technologies Revenue in Cancer Respiratory Biopsy Business (2020-2025) & (US$ Million)

 Table 86. Syft Technologies Recent Development

 Table 87. Breathe Biomedical Company Details

 Table 88. Breathe Biomedical Business Overview

 Table 89. Breathe Biomedical Cancer Respiratory Biopsy Product

 Table 90. Breathe Biomedical Revenue in Cancer Respiratory Biopsy Business (2020-2025) & (US$ Million)

 Table 91. Breathe Biomedical Recent Development

 Table 92. Vocxi Health Company Details

 Table 93. Vocxi Health Business Overview

 Table 94. Vocxi Health Cancer Respiratory Biopsy Product

 Table 95. Vocxi Health Revenue in Cancer Respiratory Biopsy Business (2020-2025) & (US$ Million)

 Table 96. Vocxi Health Recent Development

 Table 97. BREAX Biotech Company Details

 Table 98. BREAX Biotech Business Overview

 Table 99. BREAX Biotech Cancer Respiratory Biopsy Product

 Table 100. BREAX Biotech Revenue in Cancer Respiratory Biopsy Business (2020-2025) & (US$ Million)

 Table 101. BREAX Biotech Recent Development

 Table 102. ChromX Health Company Details

 Table 103. ChromX Health Business Overview

 Table 104. ChromX Health Cancer Respiratory Biopsy Product

 Table 105. ChromX Health Revenue in Cancer Respiratory Biopsy Business (2020-2025) & (US$ Million)

 Table 106. ChromX Health Recent Development

 Table 107. Sunvou Medical Company Details

 Table 108. Sunvou Medical Business Overview

 Table 109. Sunvou Medical Cancer Respiratory Biopsy Product

 Table 110. Sunvou Medical Revenue in Cancer Respiratory Biopsy Business (2020-2025) & (US$ Million)

 Table 111. Sunvou Medical Recent Development

 Table 112. MaiAoTech Company Details

 Table 113. MaiAoTech Business Overview

 Table 114. MaiAoTech Cancer Respiratory Biopsy Product

 Table 115. MaiAoTech Revenue in Cancer Respiratory Biopsy Business (2020-2025) & (US$ Million)

 Table 116. MaiAoTech Recent Development

 Table 117. Hanon Instruments Company Details

 Table 118. Hanon Instruments Business Overview

 Table 119. Hanon Instruments Cancer Respiratory Biopsy Product

 Table 120. Hanon Instruments Revenue in Cancer Respiratory Biopsy Business (2020-2025) & (US$ Million)

 Table 121. Hanon Instruments Recent Development

 Table 122. WIM Spirare Company Details

 Table 123. WIM Spirare Business Overview

 Table 124. WIM Spirare Cancer Respiratory Biopsy Product

 Table 125. WIM Spirare Revenue in Cancer Respiratory Biopsy Business (2020-2025) & (US$ Million)

 Table 126. WIM Spirare Recent Development

 Table 127. Research Programs/Design for This Report

 Table 128. Key Data Information from Secondary Sources

 Table 129. Key Data Information from Primary Sources

 Table 130. Authors List of This Report

List of Figures

 Figure 1. Cancer Respiratory Biopsy Picture

 Figure 2. Global Cancer Respiratory Biopsy Market Size Comparison by Type (2020-2031) & (US$ Million)

 Figure 3. Global Cancer Respiratory Biopsy Market Share by Type: 2024 VS 2031

 Figure 4. Mass Spectrometry Technology Based Respiratory Detection Features

 Figure 5. Gas Chromatography-Mass Spectrometry Based Respiratory Detection Features

 Figure 6. Sensor Based Respiratory Detection Features

 Figure 7. Global Cancer Respiratory Biopsy Market Size by Application (2020-2031) & (US$ Million)

 Figure 8. Global Cancer Respiratory Biopsy Market Share by Application: 2024 VS 2031

 Figure 9. Lung Cancer Early Screening Case Studies

 Figure 10. Colorectal Cancer Detection Case Studies

 Figure 11. Liver Cancer Detection Case Studies

 Figure 12. Esophageal Cancer Detection Case Studies

 Figure 13. Others Case Studies

 Figure 14. Cancer Respiratory Biopsy Report Years Considered

 Figure 15. Global Cancer Respiratory Biopsy Market Size (US$ Million), Year-over-Year: 2020-2031

 Figure 16. Global Cancer Respiratory Biopsy Market Size, (US$ Million), 2020 VS 2024 VS 2031

 Figure 17. Global Cancer Respiratory Biopsy Market Share by Region: 2024 VS 2031

 Figure 18. Global Cancer Respiratory Biopsy Market Share by Players in 2024

 Figure 19. Global Cancer Respiratory Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

 Figure 20. The Top 10 and 5 Players Market Share by Cancer Respiratory Biopsy Revenue in 2024

 Figure 21. North America Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 22. North America Cancer Respiratory Biopsy Market Share by Country (2020-2031)

 Figure 23. United States Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 24. Canada Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 25. Europe Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 26. Europe Cancer Respiratory Biopsy Market Share by Country (2020-2031)

 Figure 27. Germany Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 28. France Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 29. U.K. Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 30. Italy Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 31. Russia Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 32. Nordic Countries Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 33. Asia-Pacific Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 34. Asia-Pacific Cancer Respiratory Biopsy Market Share by Region (2020-2031)

 Figure 35. China Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 36. Japan Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 37. South Korea Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 38. Southeast Asia Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 39. India Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 40. Australia Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 41. Latin America Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 42. Latin America Cancer Respiratory Biopsy Market Share by Country (2020-2031)

 Figure 43. Mexico Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 44. Brazil Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 45. Middle East & Africa Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 46. Middle East & Africa Cancer Respiratory Biopsy Market Share by Country (2020-2031)

 Figure 47. Turkey Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 48. Saudi Arabia Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 49. UAE Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 50. Owlstone Medical Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)

 Figure 51. Breath Diagnostics Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)

 Figure 52. Menssana Research Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)

 Figure 53. Sensigent Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)

 Figure 54. Alpha Szenszor Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)

 Figure 55. NanoScent Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)

 Figure 56. Spira Innovation Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)

 Figure 57. Syft Technologies Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)

 Figure 58. Breathe Biomedical Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)

 Figure 59. Vocxi Health Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)

 Figure 60. BREAX Biotech Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)

 Figure 61. ChromX Health Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)

 Figure 62. Sunvou Medical Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)

 Figure 63. MaiAoTech Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)

 Figure 64. Hanon Instruments Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)

 Figure 65. WIM Spirare Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)

 Figure 66. Bottom-up and Top-down Approaches for This Report

 Figure 67. Data Triangulation

 Figure 68. Key Executives Interviewed